PMS Essentials
En vente sur le marché américain (selon le DSLD)
Pure Encapsulations, food supplement from the US market
PMS Essentials (Pure Encapsulations), a food supplement au code-barres 766298012971, is described by its US market label. If sold in France, it would be subject to 3 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 20 µg a day according to the label (at most 2 servings a day), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Vitamine E: up to 268 mg a day according to the label (at most 2 servings a day), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 66 mg a day according to the label (at most 2 servings a day), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- À vérifier
Vitamine B6: up to 66 mg a day according to the label, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
Source: EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), limite supérieure de sécurité (UL).
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Pure Encapsulations
- Barcode
- 766298012971
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Cellulose, Water, Food Starch, Modified, Corn Starch, Modified, Ascorbyl Palmitate, Silicon Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin D | Vitamin | 10 µg |
| Vitamin E | Vitamin | 134 mg |
| Vitamin B6 | Vitamin | 33 mg |
| DimaCal | Mineral | 100 mg |
| Magnesium | Mineral | 100 mg |
| Chaste Tree Fruit Extract | Plant | 200 mg |
| Relora Proprietary Blend | Blend | 270 mg |
| Magnolia Bark Extract | Plant | not stated |
| Phellodendron Bark Extract | Plant | not stated |
| Rhodiola Root Extract | Plant | 50 mg |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: ProSoothe II
Entered into DSLD on 22 November 2022. En vente sur le marché américain (selon le DSLD).- Same quantity, different name: Calcium in this version; DimaCal on the displayed label (100 mg)
- Same quantity, different name: Relora Patented Proprietary Blend in this version; Relora Proprietary Blend on the displayed label (270 mg)
Official label: ProSoothe II
Entered into DSLD on 25 March 2021. Retirée du marché américain le 22 March 2022 (selon le DSLD).- Active ingredient added : Magnolia (Magnolia officinalis) extract (quantity not stated)
- Active ingredient added : Phellodendron (Phellodendron amurense) extract (quantity not stated)
- Active ingredient removed : Magnolia Bark Extract (quantity not stated)
- Active ingredient removed : Phellodendron Bark Extract (quantity not stated)
- Same quantity, different name: Chaste Tree (Vitex agnus-castus) extract in this version; Chaste Tree Fruit Extract on the displayed label (200 mg)
- Same quantity, different name: Calcium in this version; DimaCal on the displayed label (100 mg)
- Same quantity, different name: Relora Patented Proprietary Blend in this version; Relora Proprietary Blend on the displayed label (270 mg)
- Same quantity, different name: Rhodiola (Rhodiola rosea) extract in this version; Rhodiola Root Extract on the displayed label (50 mg)
Official label: ProSoothe II
Entered into DSLD on 23 April 2020. Retirée du marché américain le 29 October 2018 (selon le DSLD).- Active ingredient added : Magnolia (Magnolia officinalis) extract (quantity not stated)
- Active ingredient added : Phellodendron (Phellodendron amurense) extract (quantity not stated)
- Active ingredient removed : Magnolia Bark Extract (quantity not stated)
- Active ingredient removed : Phellodendron Bark Extract (quantity not stated)
- Same quantity, different name: Chaste Tree (Vitex agnus-castus) extract in this version; Chaste Tree Fruit Extract on the displayed label (200 mg)
- Same quantity, different name: Calcium in this version; DimaCal on the displayed label (100 mg)
- Same quantity, different name: Relora Patented Proprietary Blend in this version; Relora Proprietary Blend on the displayed label (270 mg)
- Same quantity, different name: Rhodiola (Rhodiola rosea) extract in this version; Rhodiola Root Extract on the displayed label (50 mg)
- Different unit, without conversion : Vitamin D: 400 IU in this version; 10 mcg on the displayed label
- Different unit, without conversion : Vitamin E: 200 IU in this version; 134 mg on the displayed label
Official label: ProSoothe II
Entered into DSLD on 21 November 2018. Retirée du marché américain le 16 December 2020 (selon le DSLD).- Active ingredient added : Magnolia (Magnolia officinalis) extract (quantity not stated)
- Active ingredient added : Phellodendron (Phellodendron amurense) extract (quantity not stated)
- Active ingredient removed : Magnolia Bark Extract (quantity not stated)
- Active ingredient removed : Phellodendron Bark Extract (quantity not stated)
- Same quantity, different name: Chaste Tree (Vitex agnus-castus) extract in this version; Chaste Tree Fruit Extract on the displayed label (200 mg)
- Same quantity, different name: Calcium in this version; DimaCal on the displayed label (100 mg)
- Same quantity, different name: Relora Patented Proprietary Blend in this version; Relora Proprietary Blend on the displayed label (270 mg)
- Same quantity, different name: Rhodiola (Rhodiola rosea) extract in this version; Rhodiola Root Extract on the displayed label (50 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vitamin D
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Pure Encapsulations
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.